Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Low-dose Cytarabine
46%
Bronchopulmonary Dysplasia
33%
Eosinophil Count
33%
Short Stature
33%
Tetraploidy
33%
Longitudinal Measurement
33%
Liver Biopsy
33%
Small-for-gestational Age
33%
Extremely Preterm Infants
33%
Down Syndrome
33%
Transient Abnormal Myelopoiesis
33%
Partial Trisomy 21
33%
Longitudinal Analysis
33%
Hypertensive Disorders of Pregnancy
33%
Nager Syndrome
33%
Hereditary Coproporphyria
33%
Neonatal Abstinence Syndrome
33%
Hydrops Fetalis
33%
Transcutaneous Bilirubinometry
33%
Transcutaneous Bilirubin
33%
Population-based Longitudinal Study
33%
Serum Nitric Oxide
33%
Accuracy Improvement
33%
Total Bilirubin
33%
Machine Learning
33%
Nitrogen Oxides
28%
Limb Shortening
25%
At Birth
23%
DYRK1A
22%
Coproporphyrinogen Oxidase
19%
Blood Draw
16%
Neural Network
16%
Phototherapy
16%
Drug Index
14%
Adrenal Insufficiency
14%
Gestational Age
13%
Birth Weight
13%
Clinical Course
11%
RUNX1 Gene
11%
SNP Array Analysis
11%
Myeloid Malignancies
11%
Liver Fibrosis
11%
Multiple Organ Failure
11%
White Blood Cell Count
11%
Pathological Findings
11%
Bilirubin Level
11%
Prematurity
9%
Week of Gestation
9%
Risk Factors
9%
Fetal MRI
8%
Medicine and Dentistry
Small for Gestational Age
66%
Neonatal Abstinence Syndrome
66%
Childbirth
37%
Long Term Survival
33%
Lung Dysplasia
33%
Trisomy 21
33%
Myelopoiesis
33%
Tetraploidy
33%
Nager Acrofacial Dysostosis
33%
Pseudoachondroplasia
33%
Partial Trisomy
33%
Hereditary Coproporphyria
33%
Coproporphyrinogen Oxidase
19%
Premature Labor
18%
Term Birth
18%
Gestational Age
14%
Bronchitis
13%
Odds Ratio
13%
Logistic Regression Analysis
12%
Medical History
11%
Lifespan
11%
Prematurity
8%
Chromosome 21
8%
SNP Array
8%
Myeloid Malignancy
8%
Disease
8%
Drug Therapy
7%
Brachydactyly
5%
Pharmacology, Toxicology and Pharmaceutical Science
Small for Date Infant
100%
Neonatal Abstinence Syndrome
66%
Disease
41%
Cytarabine
33%
Fetus Hydrops
33%
Short Stature
33%
Bilirubin
33%
Down Syndrome
33%
Premature Labor
18%
Prematurity
18%
Bronchitis
13%
Adverse Event
13%
Liver Failure
8%
Acute Leukemia
8%
